Cargando…
Implications of using whole genome sequencing to test unselected populations for high risk breast cancer genes: a modelling study
BACKGROUND: The decision to test for high risk breast cancer gene mutations is traditionally based on risk scores derived from age, family and personal cancer history. Next generation sequencing technologies such as whole genome sequencing (WGS) make wider population testing more feasible. In the UK...
Autores principales: | Warren-Gash, Charlotte, Kroese, Mark, Burton, Hilary, Pharoah, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888520/ https://www.ncbi.nlm.nih.gov/pubmed/27252788 http://dx.doi.org/10.1186/s13053-016-0052-7 |
Ejemplares similares
-
A study of elective genome sequencing and pharmacogenetic testing in an unselected population
por: Cochran, Meagan, et al.
Publicado: (2021) -
Yield of clinically reportable genetic variants in unselected cerebral palsy by whole genome sequencing
por: van Eyk, C. L., et al.
Publicado: (2021) -
Incorporating genomics into breast and prostate cancer screening: assessing the implications
por: Chowdhury, Susmita, et al.
Publicado: (2013) -
A pilot study of assessing whole genome sequencing in newborn screening in unselected children in China
por: Jian, Min, et al.
Publicado: (2022) -
Prevalence of positive atopy patch test in an unselected pediatric population
por: Fuiano, Nicola, et al.
Publicado: (2015)